Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Steroid hormones in multiple sclerosis.

El-Etr M, Vukusic S, Gignoux L, Durand-Dubief F, Achiti I, Baulieu EE, Confavreux C.

J Neurol Sci. 2005 Jun 15;233(1-2):49-54. Review.

PMID:
15878598
2.

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA.

Neurology. 2005 Apr 12;64(7):1144-51.

PMID:
15824338
3.

European validation of a standardized clinical description of multiple sclerosis.

Amato MP, Grimaud J, Achiti I, Bartolozzi ML, Adeleine P, Hartung HP, Kappos L, Thompson A, Trojano M, Vukusic S, Confavreux C; Evaluation of the EDMUS system (EVALUED) Study Group.

J Neurol. 2004 Dec;251(12):1472-80.

PMID:
15645346
4.

Clinical characteristics of responders to interferon therapy for relapsing MS.

Waubant E, Vukusic S, Gignoux L, Dubief FD, Achiti I, Blanc S, Renoux C, Confavreux C.

Neurology. 2003 Jul 22;61(2):184-9. Review.

PMID:
12874396

Supplemental Content

Loading ...
Support Center